Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

JANX - Janux Therapeutics Inc


IEX Last Trade
47.03
2.390   5.082%

Share volume: 423,888
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$44.64
2.39
5.35%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2022-08-09 2022-11-10 2023-03-10 2023-05-09 2023-08-08 2023-11-07 2024-03-08 2024-05-08
Total revenue 2.365 M 1.813 M 2.845 M 2.048 M 1.057 M 2.517 M 2.461 M 1.252 M
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 2.365 M 1.813 M 2.845 M 2.048 M 1.057 M 2.517 M 2.461 M 1.252 M
    -23.34% 56.92% -28.01% -48.39% 138.13% -2.22% -49.13%  
Operating expenses 19.626 M 19.835 M 21.111 M 22.329 M 21.805 M 18.330 M 18.598 M 21.413 M
Selling general and admin 5.540 M 6.098 M 5.677 M 6.464 M 6.881 M 6.438 M 6.357 M 7.343 M
Research and development 14.086 M 13.737 M 15.434 M 15.865 M 14.924 M 11.892 M 12.241 M 14.070 M
Total expenses 19.626 M 19.835 M 21.111 M 22.329 M 21.805 M 18.330 M 18.598 M 21.413 M
    1.06% 6.43% 5.77% -2.35% -15.94% 1.46% 15.14%  
Operating income -17.261 M -18.022 M -18.266 M -20.281 M -20.748 M -15.813 M -16.137 M -20.161 M
Ebit -17.261 M -18.022 M -18.266 M -20.281 M -20.748 M -15.813 M -16.137 M -20.161 M
Pretax income -16.888 M -16.696 M -16.065 M -17.459 M -17.508 M -11.568 M -11.758 M -14.760 M
    -1.14% -3.78% 8.68% 0.28% -33.93% 1.64% 25.53%  
Income tax 340.000 K 370.000 K -2.277 M 0.000 0.000 0.000 0.000 0.000
Net income basic -17.228 M -17.066 M -13.788 M -17.459 M -17.508 M -11.568 M -11.758 M -14.760 M
    0.94% 19.21% -26.62% -0.28% 33.93% -1.64% -25.53%  
Net income -17.228 M -17.066 M -13.788 M -17.459 M -17.508 M -11.568 M -11.758 M -14.760 M
    0.94% 19.21% -26.62% -0.28% 33.93% -1.64% -25.53%